1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
PHARMACOKINETIC.
1-C: Renal and Hepatic Elimination
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Extravascular administration: monitoring drug in urine.
Pharmacokinetics of Drug Absorption
Pharmacokinetics Questions
Nonlinear pharmacokinetics
Two-compartment model
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
1 Intravenous Infusion Equations Some drugs are administered using a continuous intravenous infusion, and if the infusion is discontinued the serum concentration/time.
Determining Elimination Rate (K)
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
1 Compartment Model: IV Dosing
Week 5- Pharmacokinetics of oral absorption
Pharmacokinetics Calculations
Week 3 - Biopharmaceutics and Pharmacokinetics
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Practical Pharmacokinetics
Week 4 - Biopharmaceutics and Pharmacokinetics
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Karunya Kandimalla, Ph.D. Assistant Professor, Pharmaceutics
Week 6- Bioavailability and Bioequivalence
3. Method of inspection Requirements for the Method of Inspection We assume that k a is much larger than k el. That is, k a is at least five times greater.
PHARMACOKINETIC MODELS
Population Pharmacokinetic Characteristics of Levosulpiride and Terbinafine in Healthy Male Korean Volunteers Yong-Bok Lee College of Pharmacy and Institute.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Intravenous bolus administration: monitoring drug in urine
One Compartment Open Model IV bolus
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Pharmacokinetic Models
Multicompartment Models
ــــــــــــــ February 17 th, PHT - LECTURE Mathematical Fundamental in Pharmacokinetics Dr. Ahmed Alalaiwe.
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
415 PHT Plasma Level – Time Curve
Pharmacokinetics 3rd Lecture
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
Compartmental Models and Volume of Distribution
Allie punke Pharmacokinetics tutoring Fall 2016
Allie punke Pharmacokinetics tutoring Fall 2016
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetic Modeling (describing what happens)
PHARMACOKINETICS Allie punke
Pharmacokinetics Tutoring
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Selected Bioavailability and Pharmacokinetic Calculations
1-C: Renal and Hepatic Elimination
Multiple ORAL Dosing Objectives
Presentation transcript:

1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ].

1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Exam Questions and Problem Sets will ask practical, application questions Recommend that you take this data and attempt to reproduce the calculations on your own.

Graph Patient Data Using semi-log paper, or Excel graph the data following oral administration of 400 mg of moxifloxacin

Graph Patient Data What model best describes this profile? Terminal elimination phase is log-linear… 1 Compartment Model with first order absorption (ka) and first order elimination (K)

Graph Patient Data What model best describes this profile? It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide )

Graph Patient Data What model best describes this profile? It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) k H = k M1 + k M2 K NR = 20% excreted into bile as unchanged drug.

Graph Patient Data What model best describes this profile? It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) K = k e + k H + k NR

Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ]. 1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) What do you calculate first? Cmax, Tmax, AUC, K, T½, V or Cl

Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ]. 1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) What do you calculate first? Cmax, Tmax, ? Does the maximum concentration actually occur at 2 hours (Tmax)? Cmax and Tmax are sampling time (data) dependant.

1-Compartment Oral Dosing Does the maximum concentration actually occur at 2 hours? Cmax and Tmax are sampling time (data) dependant and observed. Could the true maximum concentration occur at 2.5 hr??

Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ]. 1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) What do you calculate first? AUC, K and T½ can be easily calculated from available data. K from slope of log [ ] vs. time or Excel. AUC, trapezoidal rule.

1-Compartment Oral Dosing Since the concentrations between 4 and 24 hr appear log-linear, ANY pair of points in the terminal phase can be used to calculate K and half-life, AFTER CONVERSION to LOG. In Excel this would likely result in K being calculated by log-linear regression (SLOPE) of all points (4, 8, 12 and 24 hr).

1-Compartment Oral Dosing Using the concentrations at 4 and 24 hours calculate K (x 1 = 4 hr and x 2 = 24 hr) (y 1 = log (C4) = 0.248) (y 2 = log (C24) = ) Slope = (y 2 – y 1 ) / (x 2 – x 1 ) = ( – 0.248)/(24-4) = ( ) / (20) = K= slope x = x K= hr -1 T½ = / K = / = hours

1-Compartment Oral Dosing Slope = (y 2 – y 1 ) / (x 2 – x 1 ) = ( – 0.248)/(24-4) = ( ) / (20) = K= slope x = x K= hr -1 T½ = / K = / = hours

1-Compartment Oral Dosing Selection of the points from the terminal phase for calculation of K. Accurate calculation of K (T½) and all other parameters which depend on K (AUC, Cl, etc) demand that the points used to calculate K be found in the terminal phase after absorption is complete. When is absorption complete?

If absorption occurs as a first order process (constant percentage per unit time), When does absorption stop? 1-Compartment Oral Dosing If we deal with ka as we would K, Assume ka = 0.693, then T½ ka = 1 hour. This means that following a 400 mg dose, half of the dose (200 mg) will be absorbed in the first hour And half of the remaining dose (100 mg) in the second.

If absorption occurs as a first order process (constant percentage per unit time), When does absorption stop? 1-Compartment Oral Dosing Amount absorbed during each hour following the dose can be estimated as: TimeAmount (hr) (mg) Peak 25 mg/hr 100 mg/hr 6.25 mg/hr

1-Compartment Oral Dosing Amount absorbed during each hour following the dose can be estimated as: TimeAmount (hr) (mg) Peak so … when does absorption stop for this formulation? (i) At the Tmax – 2.6 hrs (ii) Prior to the peak (iii) ~ 1 hr after the peak (iv) Technically – never (v) It depends 25 mg/hr 100 mg/hr 6.25 mg/hr

1-Compartment Oral Dosing Selection of the points from the terminal phase for calculation of K. In Excel®, selection of points in the terminal phase can be completed with statistics. Evaluate the correlation coefficient (r) & the number of points. A change in r value signals the end of absorption, with confirmation by “visual inspection”.

1-Compartment Oral Dosing Selection of the points from the terminal phase for calculation of K. Notice that as you select more points to be used in the calculation of K, the K value begins to shrink, the T½ begins to increase and the correlation coefficient (r) becomes smaller. As you use more points in the absorption phase Best choice? 4 points? or 5 points?

1-Compartment Oral Dosing K hr -1 T½ hr 5 points? r

1-Compartment Oral Dosing AUC (LP-  ) AUC trapezoid AUC (0-24hr) AUC (0-  )

1-Compartment Oral Dosing AUC Analysis following Oral Absorption At time zero, even immediately following ingestion of the dose, the plasma concentration is 0 mg/L. Back extrapolation to t=0 is not appropriate, and should not be done It will not aid in the calculation of volume.

1-Compartment Oral Dosing AUC Analysis following Oral Absorption AUC should be calculated by trapezoidal rule between all concentrations. The sum of these partial areas will equal AUC 0-24hr or AUC 0-LP AUC (0-24hr)

1-Compartment Oral Dosing AUC Analysis following Oral Absorption AUC from the last measured concentration should be calculated by the pharmacokinetic method ([ ] LP /K). = (0.44 mg/L) / hr -1 = mg*hr/L = AUC LP-  AUC (0-24hr) mg*hr/L

1-Compartment Oral Dosing AUC Analysis following Oral Absorption Total AUC (0-  ) is the sum = mg*hr/L = mg*hr/L AUC (0-24hr) mg*hr/L AUC (24hr-  ) mg*hr/L

1-Compartment Oral Dosing AUC (LP-  ) AUC trapezoid AUC (0-24hr) AUC (0-  )

1-Compartment Oral Dosing AUC (LP-  ) AUC trapezoid AUC (0-24hr) AUC (0-  )

Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ]. Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Now calculate Clearance. Use the formula: Cl T = Dose / AUC Does this formula make any assumptions?

Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Clearance Cl = Dose / AUC = 400 mg / mg*hr/L = L/hr

Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Clearance Cl = Dose / AUC = K * V Assumption? that the entire dose of 400 mg was absorbed. If not what happens to V?

Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Clearance Cl = Dose / AUC = K * V Clearance Following oral absorption Cl = F x Dose / AUC where F is the fraction absorbed. So…how much was absorbed?

Calculation of Clearance Clearance Cl = Dose / AUC = 400 /33.00 = L/hr Agrees with Estimate Using Excel® =12.12 L/hr

Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ]. Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Now calculate Volume. This can be done through the use of two equations: Cl = Dose / AUC and Cl = K x V This allows: K x V = Dose / AUC and so Volume = Dose /(K x AUC) but again F? Volume = F x Dose /(K x AUC)

Calculation of Volume Volume Volume = F x Dose /(K x AUC) But because we do not know F Volume/F = Dose /(K x AUC) V/F = L Notes: A volume of 175 L is calculated when F = 1. If F = 0.9 (90%) V = If F = 0.8 (80%) V = If F = 0.7 (70%) V = If F = 0.6 …. … but what is F and how would this be determined? Volume Volume = F x Dose /(K x AUC) But because we do not know F we will assume a value of 1 (completely absorbed). Volume/F = Dose /(K x AUC) =400 / (0.069 x 33.00) V/F = L

Calculation of Volume Volume Volume = F x Dose /(K x AUC) But because we do not know F Volume/F = Dose /(K x AUC) V/F = L Notes: A volume of 175 L is calculated when F = 1. If F = 0.9 (90%) V = If F = 0.8 (80%) V = If F = 0.7 (70%) V = If F = 0.6 …. … but what is F and how would this be determined?

Calculation of Volume Volume Volume = F x Dose /(K x AUC) or because we do not know F Volume/F = Dose /(K x AUC) V/F = L Notes: A volume of 175 L is calculated when F = 1. If F = 0.9 (90%) V = Monograph (CPS) and literature indicates that the fraction absorbed is approximately 90%. Another way???

Calculation of Volume Volume Volume = F x Dose /(K x AUC) or because we do not know F Volume/F = Dose /(K x AUC) V/F = L Notes: A volume of 175 L is close to that determined by back extrapolation and calculation of a concentration of 2.3 mg/L at time zero. This appears to have worked because (i) absorption was relatively quick and (ii) elimination relatively slow (T½=10 hr).

Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ].

Concentration-time Equation Equation must include F and ka in addition to parameters found in the IV equation. Profile for a 1 compartment model with first order input and first order elimination.

Concentration-time Equation How do you calculate ka?

Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ].

Determining the Absorption Rate How can we find the rate constant associated with absorption - ka from the rising concentration time data?

Determining the Absorption Rate Terminal phase generally associated with elimination of the drug. But what is going on here? Absorption? Elimination? Absorption phase generally associated with absorption of the drug, but what is going on here? Absorption? Elimination?

Determining the Absorption Rate Terminal phase generally associated with elimination of the drug. Absorption & Elimination How can we look only at absorption?

Determining the Absorption Rate Absorption & Elimination How can we look only at absorption? We need to be able to subtract the elimination rate, to strip away one rate constant to reveal only the other. This is called the method of residuals …sometimes called feathering the curve or curve stripping.

Determining the Absorption Rate Since the terminal phase is, associated with only 1 rate constant we can back extrapolate the terminal phase to find extrapolated concentrations at each of the times where concentrations were observed during absorption. Same method used with IV 2C models.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine difference between obs. [ ] & back extrapolated [ ]. 3. Plot differences 4. Slope estimates ka.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. Recall we had a K value of hr -1 based on the last 5 points or hr -1 using the 4 and 24 hr concentrations. Using the selected K value and a point that is in the terminal phase (8, 12 or 24 hr), calculate the concentrations at 0, 0.25, 0.5, 1.0, 1.5 and 2 hr.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. Recall we had a K value of hr -1 based on the last 5 points or hr -1 using the 4 and 24 hr concentrations. Using the selected K value and a point that is in the terminal phase (8, 12 or 24 hr), calculate the concentrations at 0, 0.25, 0.5, 1.0, 1.5 and 2 hr. Completed using the K value of hr -1 determined from the last 5 points generate concentrations at every time point.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine the difference between the observed [ ] & back extrap. [ ]. Example: at 0.25 hr the back extrap conc is 2.27 mg/L and the observed concentration was 0.88 mg/L. The difference is: Diff. = 2.27 – 0.88 = 1.39 mg/L

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine the difference between the observed [ ] & back extrap. [ ]. 3.Plot differences. Diff. must be plotted as log of concentrations.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine the difference between the observed [ ] & back extrap. [ ]. 3.Plot differences. Diff. must be plotted as log of concentrations. 4.Slope estimates ka through conversion by – Slope = ; ka = hr -1

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals in Excel 1. Back extrapolate terminal phase using best r-value to guide selection. Using the K value determined from the last 5 points generate concentrations at every time point.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals in Excel 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine difference between obs [ ] & back extrapolated [ ].

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine difference between obs [ ] & back extrapolated [ ]. 3.Plot differences. Diff. must be plotted as log of concentrations.

Determining the Absorption Rate Estimation of Absorption Rate Using method of residuals 1. Back extrapolate terminal phase using best r-value to guide selection. 2. Determine difference between obs [ ] & back extrapolated [ ]. 3. Plot differences 4. Slope estimates ka.

Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ].

Concentration-time Equation Calculate expected concentrations to see how close the observed and expected concentrations are using our parameter estimates. Dose = 400 mg; T½ = 10.04;K = hr-1; ka = hr-1 Volume = L with F = 1. Observed Time Plasma Conc (hr) (mg/L)

Observed Expected Time Plasma Conc Plasma Conc (hr) (mg/L) (mg/L) Concentration-time Equation Agreement is good. Concentrations deviate by to mg/L in the first hour. This would indicate good estimation of K, with some error in ka. But volume and F are really still a combined term. What is the true F in this patient?

Questions to Consider What model & equation best describes profile? Calculate Cmax, Tmax, AUC, K, T½, V &Cl Write an equation that will calculate concentrations at anytime after the 1st dose. 4.Calculate the absorption rate – ka. 5.Comparison of Observed and Estimated [ ]. Time Plasma Conc (hr) (mg/L) Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following the dose and the plasma concentration determined. It is known that about 20% of a moxifloxacin dose is excreted in the urine unchanged. A further 20% is excreted unchanged in the bile and the rest is metabolised to either M1 ( sulpho ) or M2 ( acyl-glucuronide ) Parameters to Investigate Further F, Bioavailability and its calculation Effect of ka on profile SR products. Parameters to Investigate Further F, Bioavailability and its calculation Effect of ka on profile SR products.